Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme

被引：0
|
作者：
Nalee Kim
Joongyo Lee
Do-Hyun Nam
Jung-Il Lee
Ho Jun Seol
Doo-Sik Kong
Jung Won Choi
Kyuha Chong
Won Jae Lee
Jong Hee Chang
Seok-Gu Kang
Ju Hyung Moon
Jaeho Cho
Do Hoon Lim
Hong In Yoon
机构：
[1] Sungkyunkwan University School of Medicine,Department of Radiation Oncology, Samsung Medical Center
[2] Yonsei University College of Medicine,Department of Radiation Oncology, Yonsei Cancer Center, Severance Hospital, Yonsei University Health System
[3] Sungkyunkwan University School of Medicine,Department of Neurosurgery, Brain Tumor Center, Samsung Medical Center
[4] Yonsei University College of Medicine,Department of Neurosurgery, Severance Hospital, Yonsei University Health System
[5] Yonsei University College of Medicine,Brain Tumor Center, Severance Hospital, Yonsei University Health System
[6] Yonsei University College of Medicine,Department of Radiation Oncology, Heavy Ion Therapy Research Institute, Yonsei Cancer Center, Yonsei University Health System
来源：
Journal of Neuro-Oncology | 2023年 / 165卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：269 / 269
相关论文
共 35 条
  • [1] Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme
    Nalee Kim
    Joongyo Lee
    Do-Hyun Nam
    Jung-Il Lee
    Ho Jun Seol
    Doo-Sik Kong
    Jung Won Choi
    Kyuha Chong
    Won Jae Lee
    Jong Hee Chang
    Seok-Gu Kang
    Ju Hyung Moon
    Jaeho Cho
    Do Hoon Lim
    Hong In Yoon
    Journal of Neuro-Oncology, 2023, 165 : 261 - 268
  • [2] Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme
    Kim, Nalee
    Lee, Jongyo
    Nam, Do-Hyun
    Lee, Jung-Il
    Seol, Ho Jun
    Kong, Doo-Sik
    Choi, Jung Won
    Chong, Kyuha
    Lee, Won Jae
    Chang, Jong Hee
    Kang, Seok-Gu
    Moon, Ju Hyung
    Cho, Jaeho
    Lim, Do Hoon
    Yoon, Hong In
    JOURNAL OF NEURO-ONCOLOGY, 2023, 165 (02) : 261 - 268
  • [3] GENOMIC PREDICTORS OF ADVERSE EVENTS IN NEWLY DIAGNOSED IDH-WILDTYPE GLIOBLASTOMA
    Lim-Fat, Mary Jane
    Rahman, Rifaquat
    Muzikansky, Alona
    Woodward, Eleanor
    Whorral, Sydney
    Allen, Marie
    Touat, Mehdi
    Iorgulescu, Bryan
    Youssef, Gilbert
    Chukwueke, Ugonma
    Mcfaline-Figueroa, Jose
    Nayak, Lakshmi
    Lee, Eudocia
    Reardon, David
    Huang, Raymond
    Beroukhim, Rameen
    Bi, Wenya Linda
    Ligon, Keith
    Wen, Patrick
    NEURO-ONCOLOGY, 2020, 22 : 11 - 11
  • [4] A clinical evaluation of cystic features in patients with newly diagnosed glioblastoma with IDH-wildtype
    Kim, Min Joo
    Park, Jae -Sung
    Jeun, Sin -Soo
    Ahn, Stephen
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 228
  • [5] Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
    Wende, Tim
    Kasper, Johannes
    Prasse, Gordian
    Glass, Aenne
    Kriesen, Thomas
    Freiman, Thomas M.
    Meixensberger, Juergen
    Henker, Christian
    CANCERS, 2021, 13 (22)
  • [6] Correction to: Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma
    Steven Tobochnik
    Emily Lapinskas
    Jayne Vogelzang
    Keith L. Ligon
    Jong Woo Lee
    Journal of Neuro-Oncology, 2022, 159 : 219 - 219
  • [7] TEMPORAL HETEROGENEITY OF DNA METHYLATION SUBCLASSES BETWEEN MATCHED NEWLY DIAGNOSED AND RECURRENT IDH-WILDTYPE GLIOBLASTOMA
    Drexler, Richard
    Schueller, Ulrich
    Eckhardt, Alicia
    Sauvigny, Thomas
    Ricklefs, Tammo
    Bode, Helena
    Khatri, Robin
    Hausmann, Fabian
    Haenzelmann, Sonja
    Huber, Tobias
    Bonn, Stefan
    Lamszus, Katrin
    Westphal, Manfred
    Duehrsen, Lasse
    Ricklefs, Franz
    NEURO-ONCOLOGY, 2022, 24 : 11 - 11
  • [8] A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).
    Thomas, Reena Parada
    Nagpal, Seema
    Iv, Michael
    Soltys, Scott G.
    Corbin, Zachary
    Xu, Linda Wei
    Recht, Cathy Kahn
    Bertrand, Sophie
    Jain, Vani
    Acevedo, Brenda
    Brown, Martin
    Recht, Lawrence David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification
    Roux, Alexandre
    Elia, Angela
    Hudelist, Benoit
    Benzakoun, Joseph
    Dezamis, Edouard
    Parraga, Eduardo
    Moiraghi, Alessandro
    Simboli, Giorgia Antonia
    Chretien, Fabrice
    Oppenheim, Catherine
    Zanello, Marc
    Pallud, Johan
    JOURNAL OF NEURO-ONCOLOGY, 2024, 169 (02) : 445 - 455
  • [10] A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
    Lara-Velazquez, Montserrat
    Shireman, Jack M.
    Lehrer, Eric J.
    Bowman, Kelsey M.
    Ruiz-Garcia, Henry
    Paukner, Mitchell J.
    Chappell, Richard J.
    Dey, Mahua
    FRONTIERS IN ONCOLOGY, 2021, 11
1234